Ehingen, Germany

Christian Gege

This inventor holds 38 USPTO granted patents and 21 published patent applications, plus 9 CIPO patents and 20 EPO patents, primarily in Antiviral Compounds. Top assignees: Gilead Sciences, Inc., Janssen Pharmaceutica Nv, Innovative Molecules Gmbh. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Gege. Retrieved from https://idiyas.com/inventor/christian-gege

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 

% Patents Active = 63.2

 

 

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 105(Granted Patents)


Location History:

  • Ehingen/Donau, DE (2008 - 2013)
  • Mauer, DE (2010 - 2022)
  • Ehingen, DE (2007 - 2024)

Company Filing History:


Years Active: 2007-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antiviral Compounds
FXR Modulators
Thiazoles
Metalloprotease Inhibitors
Enantiomers
Aminothiazole Derivatives
Chronic Inflammatory Diseases
ROR Modulators
Heterocyclic Compounds
Sulfonamide Substituted
Bicyclic Core Moiety
Anti-Tumor Action
38 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christian Gege

Introduction

Christian Gege, a distinguished inventor based in Ehingen, Germany, has made significant strides in the field of medicinal chemistry, boasting an impressive portfolio of 33 patents. His work primarily focuses on compounds that target nuclear receptors, providing insights into innovative therapeutic approaches.

Latest Patents

Among Christian's latest patents are "LXR modulators with bicyclic core moiety" and "FXR (NR1H4) modulating compounds." The former relates to bicyclic compounds, such as indoles with sulfonyl moieties, which bind to the liver X receptor (LXRα and/or LXKβ) and function as inverse agonists. The latter patent encompasses compounds that bind to the NR1H4 receptor (FXR), acting as agonists. These discoveries hold promise for treating various diseases through tailored medicaments derived from these innovative compounds.

Career Highlights

Throughout his career, Christian Gege has worked with renowned companies, including Gilead Sciences, Inc. and Janssen Pharmaceutica NV. His role in these organizations has significantly contributed to the advancement of pharmaceutical innovations and research.

Collaborations

Christian has had the privilege of collaborating with esteemed colleagues Olaf Kinzel and Christoph Steeneck. These partnerships have undoubtedly enriched his research endeavors and expanded the horizons of his inventive work.

Conclusion

Christian Gege's contributions to pharmaceutical science through his patents and collaborations highlight his role as an influential inventor. With a focus on innovative therapies and a track record of impactful research, he continues to pave the way for advancements in medicinal chemistry, ultimately benefiting the healthcare field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…